UBS Group
DH icon

UBS Group’s Definitive Healthcare DH Stock Holding History

UBS Group’s Portfolio DH Stock Details DH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$40.5K Sell
48,717
-28,903
-37% -$26.5K ﹤0.01% 7690
2026
Q1 		$95.5K Sell
77,620
-249,310
-76% -$433K ﹤0.01% 7023
2025
Q4 		$938K Sell
326,930
-49,979
-13% -$139K ﹤0.01% 5631
2025
Q3 		$1.53M Sell
376,909
-99,431
-21% -$397K ﹤0.01% 5216
2025
Q2 		$1.86M Buy
476,340
+168,656
+55% +$531K ﹤0.01% 4897
2025
Q1 		$889K Buy
307,684
+227,935
+286% +$925K ﹤0.01% 5380
2024
Q4 		$328K Buy
79,749
+49,186
+161% +$215K ﹤0.01% 6145
2024
Q3 		$137K Sell
30,563
-4,311
-12% -$20.2K ﹤0.01% 6136
2024
Q2 		$190K Sell
34,874
-41,355
-54% -$260K ﹤0.01% 5687
2024
Q1 		$615K Buy
76,229
+75,615
+12,315% +$669K ﹤0.01% 5030
2023
Q4 		$6.1K Sell
614
-248
-29% -$1.95K ﹤0.01% 7728
2023
Q3 		$6.89K Sell
862
-59,133
-99% -$594K ﹤0.01% 7265
2023
Q2 		$660K Buy
59,995
+59,143
+6,942% +$609K ﹤0.01% 4587
2023
Q1 		$8.8K Sell
852
-2,863
-77% -$33.7K ﹤0.01% 7699
2022
Q4 		$40.8K Sell
3,715
-2,186
-37% -$28.1K ﹤0.01% 6961
2022
Q3 		$92K Buy
5,901
+5,395
+1,066% +$119K ﹤0.01% 5775
2022
Q2 		$12K Sell
506
-307
-38% -$6.57K ﹤0.01% 7645
2022
Q1 		$20K Sell
813
-890
-52% -$20.1K ﹤0.01% 7443
2021
Q4 		$47K Buy
+1,703
New +$59.6K ﹤0.01% 6959

Other funds holding DH

AI
Advent International Boston, Massachusetts $17.7B AUM 5.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

UBS Group's DH Position: Q2 2026 in Review

UBS Group reduced its Definitive Healthcare (DH) stake by 37% in Q2 2026, selling an estimated $26.5K and leaving 48,717 shares worth $40.5K. The position accounts for ﹤0.01% of the portfolio, ranked #7690.

UBS Group first reported a position in DH in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.86M in Q2 2025. 100 funds tracked by Wall St. Rank hold DH as of Q2 2026.

  • UBS Group held 48,717 shares of Definitive Healthcare worth $40.5K as of Q2 2026.
  • UBS Group sold 28,903 Definitive Healthcare shares in Q2 2026, an estimated $26.5K.
  • Definitive Healthcare made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #7690 holding.
  • UBS Group first reported a position in Definitive Healthcare in Q4 2021 and has held it in 19 quarters since.
  • UBS Group's Definitive Healthcare position peaked at $1.86M in Q2 2025.
  • 100 funds tracked by Wall St. Rank held Definitive Healthcare as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.